- The Vaccine Innovation Pathway: delivering results and shaping the future
- Real-world innovations in site-level delivery
- Reimagining clinical research delivery: innovative models and collaborative approaches
- Expanding primary care horizons: commercial trials in the community
- Driving innovation from industry: lessons learned and future directions
MODERATOR:
Moderator to be confirmed
In the complex world of clinical research, even meticulously planned trials can face unexpected hurdles that threaten to derail progress and encounter obstacles beyond the capabilities of a small-scale Clinical Research Organization (CRO). When studies falter, a well-executed rescue strategy with an experienced global CRO becomes crucial. Drawing from Parexel’s extensive rescue-trial experience, this presentation unveils the blueprint for successful clinical trial transitions, focusing on four key phases:
- Strategic Initiation & Planning – establishing a robust framework and standardized processes
- Comprehensive Preparation & Due Diligence – ensuring stakeholder alignment on transition plans and timelines – Conducting thorough documentation review and gap analysis
- Adaptive Execution & Transfer – How to operationalize a study transfer – Anticipating challenges and employing agile governance for real-time course corrections
- Effective Closure & Delivery – defining clear transition thresholds and success metrics – Ensuring continuity and maintaining data integrity throughout the process
Suzanne McNally, Executive Director in Portfolio Management, Parexel
Mitigating the environmental impact of clinical trials, in line with the broader imperative to address the interconnected climate and health crises.